De Novo is the route for a new type of device with no valid predicate, when its risks are low to moderate. Answer four questions to see how your device lines up.
A screening aid, not a determination. The answer follows FDA's published guidance and cites it, but only FDA decides, through a Pre-Sub, a 513(g) or the submission itself. Confirm with FDA or a qualified regulatory professional. Fees and review goals are planning figures. Nothing you answer is saved.
De Novo in plain terms covers what a request contains, what a grant creates, and when to talk to FDA first.
Other free tools: Special 510(k) · De Novo · 513(g) · Breakthrough · classification lookup · predicate search · Learn